Acquired autoantibodies to coagulation factors

Area of Science:

• Hematology
• Immunology
• Internal Medicine

Background:

• Acquired coagulation factor antibodies are classified as alloantibodies or autoantibodies.
• Alloantibodies develop in response to external antigens, often seen after blood product transfusions in patients with congenital factor deficiencies or exposure to animal proteins.
• Autoantibodies arise spontaneously without prior antigen exposure and can impair clotting factor function, accelerate clearance, or create novel protein-antibody complex functions.

Purpose of the Study:

• To review recent reports on autoantibodies against specific coagulation factors.
• To illustrate the diverse functional consequences of autoantibody formation.
• To focus on autoantibodies targeting fibrinogen, prothrombin, factor V, factor VII, factor X, and von Willebrand factor.

Main Methods:

• Literature review of recent case reports and studies.
• Analysis of documented mechanisms of autoantibody action.
• Focus on clinical and functional implications of autoantibody binding to coagulation factors.

Main Results:

• Autoantibodies can neutralize clotting factor activity, leading to impaired hemostasis.
• Antibodies can promote rapid clearance of clotting factors from circulation.
• Protein-antibody complexes can exhibit unique, sometimes procoagulant, functions.

Conclusions:

• Autoantibodies against coagulation factors represent a significant clinical challenge with diverse pathogenic mechanisms.
• Understanding these mechanisms is crucial for diagnosis and management of bleeding disorders.
• Recent research provides insights into the complex interplay between autoantibodies and the coagulation system.